Indegene Ltd.

₹429.25

-14.2 (-3.2%)

INDGN Share Price

HEALTHCARE SERVICES

As on March 13, 2026

SectorHealthcare

IndustryHEALTHCARE SERVICES

Basic IndustryHealthcare Research Analytics & Technology

Market Cap₹ 10,309 Cr

P/E Ratio25.28

Dividend Yield0.23 %

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	445.43	Bearish
10-DMA	459.66	Bearish
20-DMA	473.7	Bearish
50-DMA	485.14	Bearish
100-DMA	506.64	Bearish
200-DMA	538.54	Bearish

Historical Performance

1 Year

-16.4%

3 Years

N/A

5 Years

N/A

10 Years

N/A

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Sales	---	---	---	---	---
Operating Expenses	1,718	1,681	2,006	2,144	1,194
Other Income	1,072	763	582	259	306
Operating Profit	6,415	5,817	4,541	3,128	2,612
Interest	220	494	313	60	70
Depreciation	802	761	598	335	255
Profit Before Tax	5,393	4,586	3,630	2,265	2,315
Consolidated Net Profit	4,067	3,367	2,661	1,648	1,494
Adjusted EPS	17	15	12	7	8

Compounded Sales Growth

10 Years:64.8

5 Years:34.6

3 Years:11.3

TTM:1.9

Compounded Profit Growth

10 Years:85.9

5 Years:86.2

3 Years:19.8

TTM:3.8

Stock Price CAGR

10 Years:N/A

5 Years:N/A

3 Years:N/A

TTM:-16.4

Return on Equity

10 Years:1.8

5 Years:7.6

3 Years:12

last year:17

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Share Capital	479	444	443	4	3
Total Reserves	25,316	13,533	10,017	7,578	3,198
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	560	4,348	5,839	800	268
Other Current Liabilities	3,953	4,025	3,543	3,055	1,284
Short Term Borrowings	---	97	---	---	---
Total Liabilities	32,361	24,748	21,368	12,843	5,593
Capital Work in Progress	36	---	---	---	---
Long Term Loans & Advances	224	350	203	165	140
Currents Investments	12,897	7,965	6,140	1,199	---
Short Term Loans and Advances	601	339	362	65	6
Total Current Assets	25,300	17,908	14,487	11,300	4,593
Total Assets	32,361	24,748	21,368	12,843	5,593
Adjusted Book Value	108	63	47	34	16

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 25.28, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a weak 3-year price CAGR of -24.8%, indicating poor shareholder returns.
The stock carries a beta of 0.8, indicating volatility broadly in line with the market.
In the last financial year, the company reported an EBITDA of ₹6415 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹28393 million, indicating a large and established business.

Investment Calculator

Investment Amount:

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 818710.7

No. of Shares: 1907 (Approx)

Performance:-18.1%

P/L: ₹-181289.3

NIFTY Performance: 3.4%

1 day Top Gainers